| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-08 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |